We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Globe Life (GL) Q3: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Globe Life (GL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $3.05 per share, reflecting an increase of 12.6% compared to the same period last year. Revenues are forecasted to be $1.47 billion, representing a year-over-year increase of 5.8%.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Globe Life metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenue- Total premium' reaching $1.18 billion. The estimate suggests a change of +5.4% year over year.
Based on the collective assessment of analysts, 'Revenue- Net investment income' should arrive at $285.38 million. The estimate suggests a change of +6.9% year over year.
Analysts forecast 'Revenue- Life premium' to reach $824.21 million. The estimate suggests a change of +4.6% year over year.
It is projected by analysts that the 'Revenue- Health premium' will reach $354.32 million. The estimate indicates a year-over-year change of +7%.
Analysts expect 'Insurance Underwriting Income- Health' to come in at $97.56 million. Compared to the present estimate, the company reported $96.70 million in the same quarter last year.
The consensus estimate for 'Insurance Underwriting Income- Life' stands at $326.21 million. Compared to the current estimate, the company reported $300.09 million in the same quarter of the previous year.
Over the past month, Globe Life shares have recorded returns of +3.3% versus the Zacks S&P 500 composite's +4.5% change. Based on its Zacks Rank #3 (Hold), GL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Globe Life (GL) Q3: Wall Street Projections for Key Metrics
In its upcoming report, Globe Life (GL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $3.05 per share, reflecting an increase of 12.6% compared to the same period last year. Revenues are forecasted to be $1.47 billion, representing a year-over-year increase of 5.8%.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Globe Life metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenue- Total premium' reaching $1.18 billion. The estimate suggests a change of +5.4% year over year.
Based on the collective assessment of analysts, 'Revenue- Net investment income' should arrive at $285.38 million. The estimate suggests a change of +6.9% year over year.
Analysts forecast 'Revenue- Life premium' to reach $824.21 million. The estimate suggests a change of +4.6% year over year.
It is projected by analysts that the 'Revenue- Health premium' will reach $354.32 million. The estimate indicates a year-over-year change of +7%.
Analysts expect 'Insurance Underwriting Income- Health' to come in at $97.56 million. Compared to the present estimate, the company reported $96.70 million in the same quarter last year.
The consensus estimate for 'Insurance Underwriting Income- Life' stands at $326.21 million. Compared to the current estimate, the company reported $300.09 million in the same quarter of the previous year.
View all Key Company Metrics for Globe Life here>>>
Over the past month, Globe Life shares have recorded returns of +3.3% versus the Zacks S&P 500 composite's +4.5% change. Based on its Zacks Rank #3 (Hold), GL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>